Novo vil drøfte børsregler
Relaterede artikler
Analytiker: Novo-sag er principiel
For abonnenter
En del af Watch Medier
For abonnenter
Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.
NyhedsbrevsvilkårFor abonnenter
For abonnenter
For abonnenter
Material Scientist and Coordinator
Business Development Manager
Senior Consultant / Project Manager - Life Science (R&D & Clinical)
Head of OTC Product Development
Principal Research Scientist within Biophysical characterisation and pre-formulation
Investor Relations Manager
QP delegate Biologics, CMC
Quality Engineer for Production
Principal Quality Assurance Professional – Combination Products
Skilled Process Specialist for managing logistic and production processes in SAP
QA/RA Specialist, Patient Handling Division
Governmental Public Affairs & Communications Head
Senior Laboratory Technician (Laborant) – Biophysical Protein Characterization
Environmental Monitoring Professional
ESG Officer
QA Manager GMP
Global Head of Rewards
Senior Legal Counsel
Produktionskemiker
Healthcare Compliance Senior Specialist (Associated Director), Ascendis Pharma
Principal Bioinformatic Scientist, Antibody Technology
Head of Quality Assurance